Take this benchmark to assess how much you would benefit from taking the course on the Medicare Drug Price Negotiation Program Final Rule.
This short pre-course check helps you gauge your readiness on policy intent, operational impact, equity and access, data readiness, and compliance risk under the new rule. The questions focus on trade‑offs and real‑world implications—not memorizing dates or definitions.
- See your gaps fast: Identify where you may misjudge negotiation levers, formulary duties, biosimilar timing, or CMP risks.
- Learn what matters most: Understand how the Maximum Fair Price (MFP) changes workflows, who benefits first, and where plans and manufacturers have to adapt.
- Start implementation‑ready: Use your results to target the modules that turn policy into action—data submissions, stakeholder engagement, and point‑of‑sale execution.
By the end, you’ll know whether you need a quick refresher or the full course to confidently implement the rule and avoid costly missteps. Your answers won’t be graded—this is for your own calibration.



